Why Is Heart Disease-Focused Milestone Pharmaceuticals Stock Plummeting Today?

Milestone Pharmaceuticals Inc MIST announced Tuesday that the Company received a Refusal to File (RTF) letter from the FDA for the New Drug Application seeking approval for self-administered etripamil nasal spray for paroxysmal supraventricular tachycardia (PSVT). Upon preliminary review, the FDA…

#mist #rtf #fda #newdrugapplication #nda